Cargando…

Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review

The purpose of this systematic review was to map out and summarize scientific evidence on dysregulated microRNAs (miRNAs) that can be possible biomarkers or therapeutic targets for cisplatin nephrotoxicity and have already been tested in humans, animals, or cells. In addition, an in silico analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Godoy Torso, Nadine, Pereira, João Kleber Novais, Visacri, Marília Berlofa, Vasconcelos, Pedro Eduardo Nascimento Silva, Loren, Pía, Saavedra, Kathleen, Saavedra, Nicolás, Salazar, Luis A., Moriel, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657822/ https://www.ncbi.nlm.nih.gov/pubmed/34884570 http://dx.doi.org/10.3390/ijms222312765

Ejemplares similares

Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
por: Loren, Pía, et al.
Publicado: (2022)

Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update
por: Loren, Pía, et al.
Publicado: (2021)

MicroRNAs Involved in Intrinsic Apoptotic Pathway during Cisplatin-Induced Nephrotoxicity: Potential Use of Natural Products against DDP-Induced Apoptosis
por: Loren, Pía, et al.
Publicado: (2022)

Assessment of Renal Function in Head and Neck Cancer Patients Treated with Cisplatin: Different Biomarkers and Acute Kidney Injury Classifications
por: de Godoy Torso, Nadine, et al.
Publicado: (2022)

Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field
por: Visacri, Marília B, et al.
Publicado: (2021)

Leukocytoclastic vasculitis complicating cisplatin + radiation treatment for laryngeal cancer: a case report
por: Quintanilha, Júlia Coelho França, et al.
Publicado: (2017)

Adverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study
por: Visacri, Marília Berlofa, et al.
Publicado: (2017)

Cost analysis of pharmaceutical care provided to HIV-infected patients: an ambispective controlled study
por: Carnevale, Renata Cavalcanti, et al.
Publicado: (2015)

Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection
por: Molino, Caroline de Godoi Rezende Costa, et al.
Publicado: (2014)

Role of pharmacist during the COVID-19 pandemic: A scoping review
por: Visacri, Marília Berlofa, et al.
Publicado: (2021)

Adverse Drug Reactions and quality deviations monitored by spontaneous reports
por: Visacri, Marília Berlofa, et al.
Publicado: (2015)

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
por: Quintanilha, Julia C. F., et al.
Publicado: (2021)

Data Normalization of Urine miRNA Profiling from Head and Neck Cancer Patients Treated with Cisplatin
por: Torso, Nadine de Godoy, et al.
Publicado: (2023)

Do Genetic Polymorphisms Modulate Response Rate and Toxicity of Cisplatin Associated With Radiotherapy in Laryngeal Squamous Cell Carcinoma?: A Case Report
por: Lopes-Aguiar, Leisa, et al.
Publicado: (2015)

Evaluation of the quality of life of patients before treatment of squamous cell carcinoma of the head and neck by means of chemoradiotherapy
por: Visacri, Marília Berlofa, et al.
Publicado: (2015)

Mechanisms of Cisplatin Nephrotoxicity
por: Miller, Ronald P., et al.
Publicado: (2010)

Prevention of cisplatin nephrotoxicity
por: Hayati, Fatemeh, et al.
Publicado: (2015)

Role of pharmacist in the management of Hansen's Disease: A scoping review
por: de Oliveira Duarte, Elza Cristina, et al.
Publicado: (2023)

Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results
por: Nicoletti, Aline de Souza, et al.
Publicado: (2022)

Amelioration of cisplatin-induced nephrotoxicity by statins
por: Maheshwari, Rajesh A., et al.
Publicado: (2013)

Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients
por: Nogueira, Guilherme Augusto Silva, et al.
Publicado: (2018)

Cisplatin Resistance: Genetic and Epigenetic Factors Involved
por: Lugones, Yuliannis, et al.
Publicado: (2022)

Effect of infliximab against cisplatin-induced nephrotoxicity
por: Cure, Erkan, et al.
Publicado: (2014)

Renoprotective effects of antioxidants against cisplatin nephrotoxicity
por: Hajian, Shabnam, et al.
Publicado: (2014)

Cisplatin therapy and the problem of gender-related nephrotoxicity
por: Nasri, Hamid
Publicado: (2013)

Aging increases the susceptibility of cisplatin-induced nephrotoxicity
por: Wen, Jiagen, et al.
Publicado: (2015)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Time course of cisplatin-induced nephrotoxicity and hepatotoxicity
por: Pezeshki, Zahra, et al.
Publicado: (2017)

Evaluating dose of cisplatin responsible for causing nephrotoxicity
por: Higuchi, Kyouko, et al.
Publicado: (2019)

Citrus aurantium Ameliorates Cisplatin-Induced Nephrotoxicity
por: Wang, Rui, et al.
Publicado: (2019)

Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy
por: Hu, Xiaoru, et al.
Publicado: (2021)

XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation
por: Lopes-Aguiar, Leisa, et al.
Publicado: (2016)

Cisplatin Nephrotoxicity and Protection by Milk Thistle Extract in Rats
por: Karimi, Gholamreza, et al.
Publicado: (2005)

Comparative Nephrotoxicity of Cisplatin and Nedaplatin: Mechanisms and Histopathological Characteristics
por: Uehara, Takeki, et al.
Publicado: (2011)

Renal protective effect of selenium on cisplatin-induced nephrotoxicity
por: Ghorbani, Ali
Publicado: (2012)

Protective effects of ethyl pyruvate in cisplatin-induced nephrotoxicity
por: Kelle, Ilker, et al.
Publicado: (2014)

Plant-Derived Agents for Counteracting Cisplatin-Induced Nephrotoxicity
por: Ojha, Shreesh, et al.
Publicado: (2016)

Renal protective effect of polysulfide in cisplatin-induced nephrotoxicity
por: Cao, Xu, et al.
Publicado: (2018)

Oxytocin ameliorates cisplatin-induced nephrotoxicity in Wistar rats
por: Elberry, Ahmed A., et al.
Publicado: (2013)

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
por: Zazuli, Zulfan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jqcuu6t5k05bk0sf8cig58s1fb